Back to Blog
CAFC-PTOAugust 3, 2026·26-1904, 26-1905·Dismissed; mandate issued August 3, 2026.

Integrated DNA Technologies, Inc. v. Tecan Genomics, Inc.

Patent Trial and Appeal Board

Holding

The Federal Circuit dismissed the appeal under Federal Rule of Appellate Procedure 42(b) based on the parties’ agreement. Each side will bear its own costs.

Why It Matters

This is a nonprecedential voluntary dismissal order with no substantive patent-law ruling, but it ends the Federal Circuit review of the PTAB proceeding.

Full Summary

Integrated DNA Technologies, Inc. v. Tecan Genomics, Inc. The Federal Circuit dismissed the appeal under Federal Rule of Appellate Procedure 42(b) based on the parties’ agreement. Each side will bear its own costs. This is a nonprecedential voluntary dismissal order with no substantive patent-law ruling, but it ends the Federal Circuit review of the PTAB proceeding. Dismissed; mandate issued August 3, 2026. The appeal arose from a PTAB inter partes review, IPR2025-00016. The parties jointly agreed to dismissal of the Federal Circuit proceeding. The court dismissed under Fed. R. App. P. 42(b). No patentability, claim construction, or other merits issue was decided. Each side bears its own costs, and the order issued as the mandate the same day. non-precedential claim construction non-precedential claim construction non-precedential

Key Points

  • The appeal arose from a PTAB inter partes review, IPR2025-00016.
  • The parties jointly agreed to dismissal of the Federal Circuit proceeding.
  • The court dismissed under Fed. R. App. P. 42(b).
  • No patentability, claim construction, or other merits issue was decided.
  • Each side bears its own costs, and the order issued as the mandate the same day.
non-precedentialclaim construction

More on this topic